HSCS — HeartSciences Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1468492 ·
Last close
$1.82
Market Cap
$5.80M
52W High
$2.77
52W Low
$1.63
ADV30
39,890
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 0 | 0 | -1,928,940 | -1,985,208 | 7,554,503 | 3,397,035 | 4,902,380 |
| Oct 2025 | 2,419 | 1,411 | -2,073,403 | -2,350,769 | 5,996,117 | 1,951,103 | 1,813,647 |
| Jul 2025 | 1,900 | 1,140 | -1,874,119 | -2,054,994 | 6,437,186 | 2,792,231 | 3,296,075 |
| Apr 2025 | 4,350 | 2,470 | -1,920,399 | -2,094,330 | 4,222,909 | 1,098,098 | 4,017,738 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,340,799
Investing CF
$-52,264
Financing CF
$8,193,576
CapEx
$-52,264
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.63
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-82,518,606
Inventory
$657,285
Receivables
$0
ST Investments
—
EBIT TTM
$-7,779,718
Pretax Income TTM
$-8,485,301
Interest Exp TTM
$705,583
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$8,669
EBITDA
$-7,768,315
Free Cash Flow
$-4,213,324
Enterprise Value
$6,490,096
Total Cash
$3,397,035
Total Debt
$3,867,131
Shares Out
3,184,700
Trailing EPS
$-4.49
Book Value
$0.83
ROE
-382.3%
ROA
-73.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Apr 2025 | 4,350 | -8,352,571 | -8,765,229 | 4,222,909 | 4,017,738 | — | -7,412,994 |
| Apr 2024 | 18,600 | -6,305,770 | -6,605,208 | 9,503,113 | 2,185,812 | — | -6,070,185 |
| Apr 2023 | 5,150 | -6,112,964 | -6,354,290 | 3,287,233 | 3,056,676 | — | -5,773,577 |
| Apr 2022 | 14,373 | -4,709,399 | -4,828,260 | 2,089,448 | 8,145,244 | — | -3,644,144 |
TTM Snapshot
Revenues TTM
$1,900
NetIncome TTM
$-2,054,994
OpCashFlow TTM
$0
Assets (Latest)
$4,222,909
Forward EPS
$-2.83
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NXGL | NEXGEL, INC. | $5.64M | $0.61 | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $5.38M | $2.25 | — |
| NDRA | ENDRA Life Sciences Inc. | $6.36M | $5.01 | — |
| USAQ | QHSLab, Inc. | $5.26M | $0.35 | — |
| NVNO | enVVeno Medical Corp | $6.81M | $10.20 | — |
News headlines (Yahoo Finance, 1h cache)
European Patent Granted for ECG-Based Assessment of Diastolic Function, Expands HeartSciences’ Patent Portfolio to More Than 45 Granted Patents
2026-06-11 12:30 · Yahoo
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
2026-06-02 12:30 · Yahoo
HeartSciences Signs Commercial Agreement with North Shore Health, the First Hospital Deployment from the Cibolo Health Network
2026-05-19 12:30 · Yahoo
HeartSciences Signs First SaaS Revenues Agreement following full launch of MyoVista Insights™
2026-05-05 13:00 · Yahoo
HeartSciences Reminds Its Shareholders to Submit Their Vote at the Upcoming April 30, 2026, Annual Shareholders Meeting
2026-04-14 20:15 · Yahoo
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
2026-03-25 12:30 · Yahoo
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
2026-03-24 15:18 · Yahoo
Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)
2026-03-20 12:00 · Yahoo
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
2026-03-16 20:15 · Yahoo
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
2026-02-05 13:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.